We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
-16.43%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$791B
AUM Growth
-$200B
Cap. Flow
-$11.4B
Cap. Flow %
-1.44%
Top 10 Hldgs %
26.42%
Holding
3,063
New
88
Increased
1,490
Reduced
1,207
Closed
101

Top Buys

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$3.46B
2
UNH icon
UnitedHealth
UNH
+$2.79B
3
CRM icon
Salesforce
CRM
+$2.38B
4
SHW icon
Sherwin-Williams
SHW
+$1.41B
5
PM icon
Philip Morris
PM
+$1.34B

Sector Composition

Rank Sector Weight
1 Technology 26.68%
2 Healthcare 19.49%
3 Consumer Discretionary 13.07%
4 Financials 11.17%
5 Communication Services 8.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EUCR
2551
DELISTED
Eucrates Biomedical Acquisition Corp. Ordinary Shares
EUCR
$222K ﹤0.01%
22,427
CLVS
2552
DELISTED
Clovis Oncology, Inc.
CLVS
$222K ﹤0.01%
123,450
-49,490
-29% -$73K
PBIP
2553
DELISTED
Prudential Bancorp, Inc.
PBIP
$222K ﹤0.01%
14,685
GLNG icon
2554
Golar LNG
GLNG
$5.25B
$220K ﹤0.01%
9,650
+566
+6% +$13.5K
TOON icon
2555
Kartoon Studios
TOON
$38.2M
$219K ﹤0.01%
28,910
+8,944
+45% +$68.5K
GNE icon
2556
Genie Energy
GNE
$386M
$218K ﹤0.01%
23,842
YMAB
2557
DELISTED
Y-mAbs Therapeutics
YMAB
$218K ﹤0.01%
14,423
+258
+2% +$3.01K
IMGN
2558
DELISTED
Immunogen Inc
IMGN
$218K ﹤0.01%
48,413
+1,420
+3% +$6.17K
CWH icon
2559
Camping World
CWH
$680M
$217K ﹤0.01%
10,071
+1,635
+19% +$43.2K
CAMP
2560
DELISTED
CalAmp Corp.
CAMP
$217K ﹤0.01%
2,265
+39
+2% +$5.43K
PSNL icon
2561
Personalis
PSNL
$1.54B
$216K ﹤0.01%
62,600
+30,261
+94% +$154K
XLK icon
2562
State Street Technology Select Sector SPDR ETF
XLK
$125B
$216K ﹤0.01%
3,400
CVGI icon
2563
Commercial Vehicle Group
CVGI
$129M
$215K ﹤0.01%
36,800
-3,008
-8% -$20.5K
KYNB
2564
Kyntra Bio
KYNB
$28.6M
$215K ﹤0.01%
814
+117
+17% +$29.9K
HVT icon
2565
Haverty Furniture Companies
HVT
$448M
$215K ﹤0.01%
9,258
+1
+0% +$27
VWO icon
2566
Vanguard FTSE Emerging Markets ETF
VWO
$126B
$215K ﹤0.01%
+5,170
New +$223K
ASUR icon
2567
Asure Software
ASUR
$250M
$214K ﹤0.01%
37,480
+1,700
+5% +$10.1K
INBK icon
2568
First Internet Bancorp
INBK
$255M
$214K ﹤0.01%
5,807
+57
+1% +$2.19K
SSRM icon
2569
SSR Mining
SSRM
$6.49B
$214K ﹤0.01%
+12,817
New +$265K
NPKI
2570
NPK International
NPKI
$1.18B
$213K ﹤0.01%
68,961
-6,159
-8% -$23.6K
ROCC
2571
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
$213K ﹤0.01%
6,474
-2,035
-24% -$76.6K
CRDO icon
2572
Credo Technology Group
CRDO
$49.9B
$212K ﹤0.01%
18,167
+224
+1% +$2.6K
FOR icon
2573
Forestar Group
FOR
$1.49B
$212K ﹤0.01%
15,455
+221
+1% +$3.48K
ABCL icon
2574
AbCellera Biologics
ABCL
$3.28B
$210K ﹤0.01%
+19,759
New +$167K
LEVI icon
2575
Levi Strauss
LEVI
$8.62B
$209K ﹤0.01%
12,800
+1,300
+11% +$23.5K

Similar funds

T. Rowe Price Associates's Q2 2022 Portfolio in Review

As of Q2 2022, T. Rowe Price Associates held 3,063 positions worth $791B, down 20% from $992B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

T. Rowe Price Associates's Q2 2022 filing shows 88 new, 1,490 increased, 1,207 reduced and 101 closed positions. Its largest new stake was ESAB: 6,073,363 shares worth $266M. The largest sale was Meta Platforms (Facebook), an estimated $4.44B.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q2 2022 buy was ESAB: 6,073,363 shares worth $266M.
  • T. Rowe Price Associates added most to Becton Dickinson in Q2 2022, an estimated $3.46B increase.
  • T. Rowe Price Associates's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $4.44B.
  • T. Rowe Price Associates fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $364M.
  • T. Rowe Price Associates's ten largest holdings make up 26% of its $791B portfolio in Q2 2022.
  • T. Rowe Price Associates opened 88 new positions and closed 101 in Q2 2022.
  • T. Rowe Price Associates's portfolio value fell 20% quarter-over-quarter to $791B.

Based on T. Rowe Price Associates's 13F filing for Q2 2022, filed 15 Aug 2022.